Light Mode
$18.90 ↓ -0.09 (-0.47%) Trading Down from the previous close of $18.99
-6.01 (-24.04%) / 6M
Momentum, market sentiment, and recent alerts
APMD reads neutral: the 12-month move is -24.0%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Apnimed, Inc. operates as a clinical-stage company. It engages in the discovery, development, and commercialization of oral therapies for sleep-related breathing diseases. The company was founded by Lawrence G. Miller, Barry Wohl and Luigi Taranto Montemurro in 2017 and is headquartered in Cambridge, MA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.